Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Grifols SA (GRFS)
NASDAQ:GRFS
Grifols SA (GRFS) Stock Price & Analysis
285 Followers
GRFS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.71 - $13.10
Previous Close$8.85
Volume535.68K
Average Volume (3M)878.98K
Market Cap
€7.02B
Enterprise Value$7.88B
Total Cash (Recent Filing)€1.96B
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)27.0
Beta0.73
Next Earnings
Jul 27, 2023EPS Estimate
$0.19Last Dividend Ex-Date
Jun 03, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)0.33
Shares Outstanding261,430,000
10 Day Avg. Volume462,025
30 Day Avg. Volume878,976
Standard Deviation0.09
R-Squared0.05
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-0.25
Price to Sales (P/S)0.38
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$16.87Price Target Upside86.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Grifols SA News
Pre-EarningsGrifols SA (GRFS) Q1 Earnings Cheat Sheet
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GRFS FAQ
What was Grifols SA’s price range in the past 12 months?
Grifols SA lowest stock price was $5.71 and its highest was $13.10 in the past 12 months.
What is Grifols SA’s market cap?
Currently, no data Available
When is Grifols SA’s upcoming earnings report date?
Grifols SA’s upcoming earnings report date is Jul 27, 2023 which is in 49 days.
How were Grifols SA’s earnings last quarter?
Grifols SA released its earnings results on May 09, 2023. The company reported $0.044 earnings per share for the quarter, missing the consensus estimate of $0.159 by -$0.115.
Is Grifols SA overvalued?
According to Wall Street analysts Grifols SA’s price is currently Undervalued.
Does Grifols SA pay dividends?
Grifols SA pays a Annually dividend of $0.34 which represents an annual dividend yield of N/A. See more information on Grifols SA dividends here
What is Grifols SA’s EPS estimate?
Grifols SA’s EPS estimate is $0.19.
How many shares outstanding does Grifols SA have?
Grifols SA has 261,425,100 shares outstanding.
What happened to Grifols SA’s price movement after its last earnings report?
Grifols SA reported an EPS of $0.044 in its last earnings report, missing expectations of $0.159. Following the earnings report the stock price went up 10.45%.
Which hedge fund is a major shareholder of Grifols SA?
Among the largest hedge funds holding Grifols SA’s share is Brandes Investment Partners LP. It holds Grifols SA’s shares valued at 76M.
---
Grifols SA Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$16.87 (86.41% Upside)
$16.87 (86.41% Upside)
Blogger Sentiment
Bullish
GRFS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 2.6M Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
-29.24%
12-Months-Change
Fundamentals
Return on Equity
3.30%
Trailing 12-Months
Asset Growth
5.27%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Grifols SA
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
---
Top 5 ETFs holding GRFS
iShares NASDAQ US Biotechnology UCITS ETF
$464.33K
Fidelity Nasdaq Composite Index ETF
$311.45K
Invesco Nasdaq Biotechnology ETF
$18.86K
Up to five ETFs with an Outperform Smart Score that hold GRFS. The ETFs are listed according to market value of GRFS within the ETF
---
---